The Antiviral Mechanism of an Influenza A Virus Nucleoprotein-Specific Single-Domain Antibody Fragment
ABSTRACT Alpaca-derived single-domain antibody fragments (VHHs) that target the influenza A virus nucleoprotein (NP) can protect cells from infection when expressed in the cytosol. We found that one such VHH, αNP-VHH1, exhibits antiviral activity similar to that of Mx proteins by blocking nuclear im...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
American Society for Microbiology
2016-12-01
|
| Series: | mBio |
| Online Access: | https://journals.asm.org/doi/10.1128/mBio.01569-16 |
| _version_ | 1819041627010760704 |
|---|---|
| author | Leo Hanke Kevin E. Knockenhauer R. Camille Brewer Eline van Diest Florian I. Schmidt Thomas U. Schwartz Hidde L. Ploegh |
| author_facet | Leo Hanke Kevin E. Knockenhauer R. Camille Brewer Eline van Diest Florian I. Schmidt Thomas U. Schwartz Hidde L. Ploegh |
| author_sort | Leo Hanke |
| collection | DOAJ |
| description | ABSTRACT Alpaca-derived single-domain antibody fragments (VHHs) that target the influenza A virus nucleoprotein (NP) can protect cells from infection when expressed in the cytosol. We found that one such VHH, αNP-VHH1, exhibits antiviral activity similar to that of Mx proteins by blocking nuclear import of incoming viral ribonucleoproteins (vRNPs) and viral transcription and replication in the nucleus. We determined a 3.2-Å crystal structure of αNP-VHH1 in complex with influenza A virus NP. The VHH binds to a nonconserved region on the body domain of NP, which has been associated with binding to host factors and serves as a determinant of host range. Several of the NP/VHH interface residues determine sensitivity of NP to antiviral Mx GTPases. The structure of the NP/αNP-VHH1 complex affords a plausible explanation for the inhibitory properties of the VHH and suggests a rationale for the antiviral properties of Mx proteins. Such knowledge can be leveraged for much-needed novel antiviral strategies. IMPORTANCE Influenza virus strains can rapidly escape from protection afforded by seasonal vaccines or acquire resistance to available drugs. Additional ways to interfere with the virus life cycle are therefore urgently needed. The influenza virus nucleoprotein is one promising target for antiviral interventions. We have previously isolated alpaca-derived single-domain antibody fragments (VHHs) that protect cells from influenza virus infection if expressed intracellularly. We show here that one such VHH exhibits antiviral activities similar to those of proteins of the cellular antiviral defense (Mx proteins). We determined the three-dimensional structure of this VHH in complex with the influenza virus nucleoprotein and identified the interaction site, which overlaps regions that determine sensitivity of the virus to Mx proteins. Our data define a new vulnerability of influenza virus, help us to better understand the cellular antiviral mechanisms, and provide a well-characterized tool to further study them. |
| first_indexed | 2024-12-21T09:28:00Z |
| format | Article |
| id | doaj.art-e70c51221c44493787a3471757f91761 |
| institution | Directory Open Access Journal |
| issn | 2150-7511 |
| language | English |
| last_indexed | 2024-12-21T09:28:00Z |
| publishDate | 2016-12-01 |
| publisher | American Society for Microbiology |
| record_format | Article |
| series | mBio |
| spelling | doaj.art-e70c51221c44493787a3471757f917612022-12-21T19:08:51ZengAmerican Society for MicrobiologymBio2150-75112016-12-017610.1128/mBio.01569-16The Antiviral Mechanism of an Influenza A Virus Nucleoprotein-Specific Single-Domain Antibody FragmentLeo Hanke0Kevin E. Knockenhauer1R. Camille Brewer2Eline van Diest3Florian I. Schmidt4Thomas U. Schwartz5Hidde L. Ploegh6Whitehead Institute for Biomedical Research, Cambridge, Massachusetts, USADepartment of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts, USAWhitehead Institute for Biomedical Research, Cambridge, Massachusetts, USAWhitehead Institute for Biomedical Research, Cambridge, Massachusetts, USAWhitehead Institute for Biomedical Research, Cambridge, Massachusetts, USADepartment of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts, USAWhitehead Institute for Biomedical Research, Cambridge, Massachusetts, USAABSTRACT Alpaca-derived single-domain antibody fragments (VHHs) that target the influenza A virus nucleoprotein (NP) can protect cells from infection when expressed in the cytosol. We found that one such VHH, αNP-VHH1, exhibits antiviral activity similar to that of Mx proteins by blocking nuclear import of incoming viral ribonucleoproteins (vRNPs) and viral transcription and replication in the nucleus. We determined a 3.2-Å crystal structure of αNP-VHH1 in complex with influenza A virus NP. The VHH binds to a nonconserved region on the body domain of NP, which has been associated with binding to host factors and serves as a determinant of host range. Several of the NP/VHH interface residues determine sensitivity of NP to antiviral Mx GTPases. The structure of the NP/αNP-VHH1 complex affords a plausible explanation for the inhibitory properties of the VHH and suggests a rationale for the antiviral properties of Mx proteins. Such knowledge can be leveraged for much-needed novel antiviral strategies. IMPORTANCE Influenza virus strains can rapidly escape from protection afforded by seasonal vaccines or acquire resistance to available drugs. Additional ways to interfere with the virus life cycle are therefore urgently needed. The influenza virus nucleoprotein is one promising target for antiviral interventions. We have previously isolated alpaca-derived single-domain antibody fragments (VHHs) that protect cells from influenza virus infection if expressed intracellularly. We show here that one such VHH exhibits antiviral activities similar to those of proteins of the cellular antiviral defense (Mx proteins). We determined the three-dimensional structure of this VHH in complex with the influenza virus nucleoprotein and identified the interaction site, which overlaps regions that determine sensitivity of the virus to Mx proteins. Our data define a new vulnerability of influenza virus, help us to better understand the cellular antiviral mechanisms, and provide a well-characterized tool to further study them.https://journals.asm.org/doi/10.1128/mBio.01569-16 |
| spellingShingle | Leo Hanke Kevin E. Knockenhauer R. Camille Brewer Eline van Diest Florian I. Schmidt Thomas U. Schwartz Hidde L. Ploegh The Antiviral Mechanism of an Influenza A Virus Nucleoprotein-Specific Single-Domain Antibody Fragment mBio |
| title | The Antiviral Mechanism of an Influenza A Virus Nucleoprotein-Specific Single-Domain Antibody Fragment |
| title_full | The Antiviral Mechanism of an Influenza A Virus Nucleoprotein-Specific Single-Domain Antibody Fragment |
| title_fullStr | The Antiviral Mechanism of an Influenza A Virus Nucleoprotein-Specific Single-Domain Antibody Fragment |
| title_full_unstemmed | The Antiviral Mechanism of an Influenza A Virus Nucleoprotein-Specific Single-Domain Antibody Fragment |
| title_short | The Antiviral Mechanism of an Influenza A Virus Nucleoprotein-Specific Single-Domain Antibody Fragment |
| title_sort | antiviral mechanism of an influenza a virus nucleoprotein specific single domain antibody fragment |
| url | https://journals.asm.org/doi/10.1128/mBio.01569-16 |
| work_keys_str_mv | AT leohanke theantiviralmechanismofaninfluenzaavirusnucleoproteinspecificsingledomainantibodyfragment AT kevineknockenhauer theantiviralmechanismofaninfluenzaavirusnucleoproteinspecificsingledomainantibodyfragment AT rcamillebrewer theantiviralmechanismofaninfluenzaavirusnucleoproteinspecificsingledomainantibodyfragment AT elinevandiest theantiviralmechanismofaninfluenzaavirusnucleoproteinspecificsingledomainantibodyfragment AT florianischmidt theantiviralmechanismofaninfluenzaavirusnucleoproteinspecificsingledomainantibodyfragment AT thomasuschwartz theantiviralmechanismofaninfluenzaavirusnucleoproteinspecificsingledomainantibodyfragment AT hiddelploegh theantiviralmechanismofaninfluenzaavirusnucleoproteinspecificsingledomainantibodyfragment AT leohanke antiviralmechanismofaninfluenzaavirusnucleoproteinspecificsingledomainantibodyfragment AT kevineknockenhauer antiviralmechanismofaninfluenzaavirusnucleoproteinspecificsingledomainantibodyfragment AT rcamillebrewer antiviralmechanismofaninfluenzaavirusnucleoproteinspecificsingledomainantibodyfragment AT elinevandiest antiviralmechanismofaninfluenzaavirusnucleoproteinspecificsingledomainantibodyfragment AT florianischmidt antiviralmechanismofaninfluenzaavirusnucleoproteinspecificsingledomainantibodyfragment AT thomasuschwartz antiviralmechanismofaninfluenzaavirusnucleoproteinspecificsingledomainantibodyfragment AT hiddelploegh antiviralmechanismofaninfluenzaavirusnucleoproteinspecificsingledomainantibodyfragment |